Tim Spelman

11.3k total citations
222 papers, 4.7k citations indexed

About

Tim Spelman is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Tim Spelman has authored 222 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 55 papers in Infectious Diseases and 48 papers in Surgery. Recurrent topics in Tim Spelman's work include Multiple Sclerosis Research Studies (29 papers), HIV/AIDS Research and Interventions (23 papers) and Total Knee Arthroplasty Outcomes (22 papers). Tim Spelman is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), HIV/AIDS Research and Interventions (23 papers) and Total Knee Arthroplasty Outcomes (22 papers). Tim Spelman collaborates with scholars based in Australia, Sweden and United States. Tim Spelman's co-authors include Peter Choong, Margaret Hellard, Michelle M. Dowsey, Sharon R. Lewin, Jan Hillert, Leon J. Worth, Lloyd Einsiedel, Helmut Butzkueven, Monica A. Slavin and María Trojano and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tim Spelman

213 papers receiving 4.6k citations

Peers

Countries citing papers authored by Tim Spelman

Since Specialization

Citations

This map shows the geographic impact of Tim Spelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Spelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Spelman more than expected).

Fields of papers citing papers by Tim Spelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Spelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Spelman. The network helps show where Tim Spelman may publish in the future.

Co-authorship network of co-authors of Tim Spelman

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Spelman. A scholar is included among the top collaborators of Tim Spelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Spelman. Tim Spelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection 2025 ·Clinical Infectious Diseases ·Jennifer Audsley, Anchalee Avihingsanon, Xin Li, Rosalind Edwards, Kathy Merlock Jackson, Nadia Warner, (unknown), Peter Revill, (unknown), Sivaporn Gatechompol, (unknown), Tim Spelman, Iskandar Azwa, Adeeba Kamarulzaman, Sharon R. Lewin, Joe Sasadeusz	1
2	Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring 2025 ·Diabetologia ·Katarina Eeg‐Olofsson, David Nathanson, Tim Spelman, (unknown), Alexander Seibold, Fleur Levrat‐Guillen, Jan Bolinder	0
3	Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a nationwide cohort study in Sweden 2025 ·Journal of Bone and Mineral Research ·Sigríður Björnsdóttir, (unknown), Michael Mannstadt, Outi Mäkitie, Tim Spelman, Olle Kämpe, Bente Langdahl	5
4	Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies 2024 ·Therapeutic Advances in Neurological Disorders ·Helmut Butzkueven, Tomáš Kalinčík, Francesco Patti, Mark Slee, Bianca Weinstock‐Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horáková, Eva Havrdová, Anneke van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, (unknown), Tim Spelman, (unknown)	2
5	Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysis 2023 ·Critical Reviews in Oncology/Hematology ·Gemma Reynolds, (unknown), Tim Spelman, (unknown), (unknown), Mary Ann Anderson, Karin Thursky, Monica A. Slavin, Benjamin W. Teh	14
6	Childhood trauma is prevalent and associated with co-occurring depression, anxiety, mania and psychosis in young people attending Australian youth mental health services 2023 ·Australian & New Zealand Journal of Psychiatry ·Sarah Bendall, (unknown), Tim Spelman, Patrick D. McGorry, Ian B. Hickie, Alison R. Yung, G. Paul Amminger, Stephen J. Wood, Christos Pantelis, Rosemary Purcell, Lisa Phillips	6
7	InvasiveScedosporiumandLomentospora prolificansInfections in Australia: A Multicenter Retrospective Cohort Study 2023 ·Open Forum Infectious Diseases ·Chin Fen Neoh, Sharon C.‐A. Chen, Amy Crowe, (unknown), Quoc Nguyen, Debbie Marriott, Jason A. Trubiano, Tim Spelman, David C. M. Kong, Monica A. Slavin	18
8	Prognostic models for clinical outcomes in patients with venous leg ulcers: A systematic review 2023 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·Vladica Veličković, (unknown), Jan Kottner, (unknown), (unknown), (unknown), Jelena Savović, Tim Spelman, Michael Clark, (unknown), Hans Smola, Neil Webb, Ewout W. Steyerberg	2
9	Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study 2023 ·Journal of Antimicrobial Chemotherapy ·Chin Fen Neoh, Sharon C.‐A. Chen, David C. M. Kong, (unknown), Quoc Nguyen, Tim Spelman, Michelle Tew, Emma Harvey, (unknown), (unknown), Surekha Tennakoon, Amy Crowe, Debbie Marriott, Jason A. Trubiano, Monica A. Slavin	2
10	Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins 2023 ·ANZ Journal of Surgery ·(unknown), (unknown), Jarrad Stevens, (unknown), Tim Spelman, (unknown), Michael Guiney, Gerard Powell, Peter Choong, Claudia Di Bella	5
11	The Impact of Sex on the Outcomes of Prosthetic Joint Infection Treatment with Debridement, Antibiotics and Implant Retention: A Systematic Review and Individual Patient Data Meta-analysis 2022 ·JAAOS Global Research and Reviews ·(unknown), (unknown), (unknown), Tim Spelman, Ernesto Muñoz-Mahamud, Jaime Lora-Tamayo, (unknown), Marjan Wouthuyzen‐Bakker, Mark J. Spangehl, Methee Chayakulkeeree, Simon W. Young, Peter Choong, Michelle M. Dowsey	7
12	Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol 2022 ·BMJ Open ·Tafireyi Marukutira, (unknown), Margaret Hellard, Jacqui Richmond, Kate Turner, Alisa Pedrana, Shannon Melody, Fay H. Johnston, Louise Owen, Wijnand van den Boom, Nick Scott, Alexander Thompson, David Iser, Tim Spelman, Mark Veitch, Mark Stoové, Joseph Doyle	1
13	Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis 2021 ·Blood Advances ·(unknown), Julien Coussement, (unknown), Tim Spelman, Smaro Lazarakis, Monica A. Slavin, Benjamin W. Teh	53
14	Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trial 2021 ·BMJ Open ·Solomon Abrha, Julia K. Christenson, John McEwen, Wubshet Tesfaye, Susana Vaz Nery, Aileen Y. Chang, Tim Spelman, Sam Kosari, Gabriel Kigen, Simon Carroll, Jörg Heukelbach, Hermann Feldmeier, Andrew Bartholomaeus, Mark Daniel, Gregory M. Peterson, Jackson Thomas	4
15	Multicentre stepped-wedge cluster randomised controlled trial of an antimicrobial stewardship programme in residential aged care: protocol for the START trial 2021 ·BMJ Open ·Natali Jokanovic, Terry Haines, Allen Cheng, Kathryn E. Holt, Sarah N. Hilmer, Yun‐Hee Jeon, Andrew J. Stewardson, Rhonda L. Stuart, Tim Spelman, Trisha Peel, Anton Y. Peleg	0
16	Influence of changing endotracheal tube cuff management on antibiotic use for ventilator-associated pneumonia in a tertiary intensive care unit 2017 ·Critical Care and Resuscitation ·Jai N. Darvall, Irani Thevarajan, (unknown), Thomas Rechnitzer, Tim Spelman, Nerina Harley	1
17	Multidetector (64+) Computed Tomography Angiography of the Lower Limb in Symptomatic Peripheral Arterial Disease 2016 ·Journal of Computer Assisted Tomography ·Jeremy C. Lim, (unknown), Andrew Owen, Tim Spelman, (unknown), Jason Chuen, Ruth Lim	7
18	First-line injectable therapy and pregnancy protect against long-term disability accrual in patients with relapse-onset multiple sclerosis 2015 ·Multiple Sclerosis Journal ·Vilija Jokubaitis, Tim Spelman, (unknown), Johannes Lorscheider, Pamela McCombe, Jeannette Lechner‐Scott, Suzanne Hodgkinson, Helmut Butzkueven	1
19	Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B 2014 ·Gut ·Michelle Giles, Kumar Visvanathan, Sharon R. Lewin, Scott Bowden, Stephen Locarnini, Tim Spelman, Joe Sasadeusz	84
20	Self-discharge by adult Aboriginal patients at Alice Springs Hospital, Central Australia: insights from a prospective cohort study 2012 ·Australian Health Review ·Lloyd Einsiedel, (unknown), (unknown), Tim Spelman, (unknown), (unknown), Hamilton Morris, (unknown), Anthony Davis	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact